Biogen Alzheimer's drug success: A big step because almost everything that came before it has failed

Biogen's big success in a new Alzheimer's drug trial wasn't just a win for the company. It comes after years of failures with every drug tested for dementia and growing doubts about the drug industry's narrow focus on amyloid proteins.